0.84% -0.045

Scynexis Inc (SCYX)

개요 뉴스 가격 이력 옵션 체인 Financials SCYX 왜 하락? 토론 예측 주식 분할

Relative Volume:

Scynexis Inc Stock (SCYX) Company Profile

Scynexis Inc

Healthcare (1074)

201-884-5485

1 EVERTRUST PLAZA, JERSEY CITY, NJ

최신 SEC 제출 서류

SCYX's Discussions on Twitter

Compare SCYX vs TAK, TEVA, HLN, ZTS, UTHR

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
SCYX Scynexis Inc	5.30	51.94M	20.34M	-24.52M	-5.92M	-3.5761
TAK Takeda Pharmaceutical Co Adr	18.45	57.90B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.36	42.89B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.60	43.41B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	75.81	31.00B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	487.61	22.35B	3.17B	1.29B	1.01B	27.09

Scynexis Inc Stock (SCYX) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2021-01-22	개시	Guggenheim	Buy
2021-01-06	개시	Cantor Fitzgerald	Overweight
2018-07-11	업그레이드	Needham	Hold → Buy
2018-06-27	개시	Maxim Group	Buy
2017-10-24	개시	Guggenheim	Buy
2017-07-10	개시	ROTH Capital	Buy
2017-05-09	다운그레이드	Needham	Buy → Hold
2017-03-03	재확인	RBC Capital Mkts	Outperform
2016-10-20	개시	H.C. Wainwright	Buy
2016-10-07	업그레이드	WBB Securities	Buy → Strong Buy
2016-10-03	재개	Brean Capital	Buy
2016-08-17	개시	Guggenheim	Buy
2016-08-09	재확인	Needham	Buy
2016-08-09	업그레이드	WBB Securities	Speculative Buy → Buy
2016-03-28	개시	Brean Capital	Buy
2015-12-29	개시	WBB Securities	Speculative Buy
2015-11-16	재확인	RBC Capital Mkts	Outperform
2015-06-10	개시	Needham	Buy
2014-05-29	개시	Canaccord Genuity	Buy
2014-05-29	개시	RBC Capital Mkts	Outperform

Scynexis Inc 주식(SCYX)의 최신 뉴스

Scynexis Inc (SCYX) 재무 분석

Scynexis Inc (SCYX)

Scynexis Inc Stock (SCYX) Company Profile

Compare SCYX vs TAK, TEVA, HLN, ZTS, UTHR

Scynexis Inc Stock (SCYX) Upgrades & Downgrades

Scynexis Inc 주식(SCYX)의 최신 뉴스

SCYNEXIS (SCYX) Market: Moves 3.60% Up to $5.33; Boundary Watch: the Near-Term Reference Band Stretches From $5.06 to $5.60 under the Current SnapshotShort Setup Alerts - vinanet.vn

SCYNEXIS (NASDAQ:SCYX) Upgraded at Wall Street Zen - MarketBeat

SCYX Q1 2026 Earnings: Deep EPS Miss and Missing Revenue Put Pipeline Execution in FocusEstimate Dispersion - Vinanet

SCYNEXIS (SCYX) investors CVI and Heights disclose 5.9% ownership stake - Stock Titan

Revenue per share of SCYNEXIS, Inc. – DUS:135 - TradingView

Free cash flow per share of SCYNEXIS, Inc. – DUS:135 - TradingView

SCYNEXIS, Inc. Earnings and Revenue – DUS:135 - TradingView

135 Forecast — Price Target — Prediction for 2027 - TradingView

SCYNEXIS, Inc.: Fundamental Analysis and Financial Ratings | 135 | US8112923094 - marketscreener.com

Great Point Partners (SCYX) reports 9.99% beneficial stake in Scynexis - Stock Titan

Results: SCYNEXIS, Inc. Confounded Analyst Expectations With A Surprise Profit - simplywall.st

SCYX Maintained by Guggenheim -- Price Target Raised to $33.00 - GuruFocus

Guggenheim raises Scynexis stock price target to $33 on drug potential - Investing.com Nigeria

Adage Capital group (SCYX) discloses 1,041,824-share SCYNEXIS stake including warrants - Stock Titan

Scynexis Inc earnings beat by $1.14, revenue topped estimates - Investing.com Nigeria

SCYNEXIS Inc (SCYX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

SCYX Looks 78.3% Undervalued on GF Value™ Despite Challenging Fu - GuruFocus

Scynexis Q2 adjusted EPS misses estimate as sales decline 82.77% - scanx.trade

Scynexis: Q2 Earnings Snapshot - AOL.com

SCYNEXIS Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times

SCYNEXIS (NASDAQ:SCYX) Announces Quarterly Earnings Results, Beats Expectations By $1.14 EPS - marketbeat.com

Scynexis Q2 swings to profit on warrant adjustment; advances drug studies - TradingView

Scynexis (NASDAQ: SCYX) lifts cash and pipeline with Q2 2026 moves - Stock Titan

SCYNEXIS, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

SCYNEXIS (NASDAQ:SCYX) Lowered to Strong Sell Rating by Wall Street Zen - MarketBeat

SCYNEXIS Inc expected to post a loss of 51 cents a shareEarnings Preview - TradingView

SCYNEXIS Inc. R (135.MU) insider ownership and holdings - Yahoo Finance Australia

SCYNEXIS Inc (SCYX) Stock News Today - TradingKey

SCYNEXIS (SCYX) Projected to Post Quarterly Earnings on Wednesday - MarketBeat

Scynexis Deadline Alert - TMX Newsfile

SCYX Q1 2026 Earnings: Wider-Than-Expected Loss of -$3.36 Per Share, Yet Stock Climbs 30.46%Segment Revenue Breakdown - vinanet.vn

Scynexis stock price target reiterated at $44.64 by Brookline - Investing.com Nigeria

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

SCYNEXIS Inc (SCYX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - tradingkey.com

SCYNEXIS Inc (SCYX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

SCYX|SCYNEXIS Inc|Price:3.560|Chg%:-0.170 - TradingKey

SCYNEXIS Inc (SCYX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

SCYNEXIS Inc (SCYX) Balance Sheet - TradingKey

SCYNEXIS Inc (SCYX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

TradingKey - TradingKey

SCYNEXIS Inc (SCYX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

SCYNEXIS Inc (SCYX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

SCYNEXIS (SCYX) Slips 5.8% as Biotech Stock Nears Critical Support at $3.54Insider Selling Alerts - Vinanet

SCYNEXIS, Inc. Revenue Breakdown – NASDAQ:SCYX - TradingView

SCYX Q1 2026 Earnings: Significant EPS Miss with No Revenue ReportedPeak Earnings Alert - vinanet.vn

SCYNEXIS, Inc. Revenue Breakdown – LSE:0L49 - TradingView

SCYNEXIS (SCYX) Slides 2.35% as Biotech Stock Tests Key Support LevelInsider Buying Alerts - dars.gov.et

SCYX Q1 2026 Earnings: Wider-than-Expected Loss as No Revenue ReportedEBITDA Estimate Trend - vinanet.vn

Federated Hermes (SCYX) group discloses 4.03% Scynexis stake in amended 13G - Stock Titan

FEDERATED HERMES, INC. Acquires 55,207 Shares of SCYNEXIS Inc - GuruFocus

Federated Hermes (SCYX) files 13G/A showing 55,207 shares (4.45%) - Stock Titan

Scynexis Inc (SCYX) 재무 분석

매출

순이익

현금흐름

주당 순 이익

SCYX과 유사한 종목